Ignite Creation Date:
2024-05-06 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05226507
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2022-01-13
Brief Title:
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
Sponsor:
Nuvectis Pharma Inc
Organization:
Nuvectis Pharma Inc
Organization Data
Organization:
Nuvectis Pharma Inc
Class:
INDUSTRY
Study ID:
NXP800-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nuvectis Pharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| European Network of Gynaecological Oncological Trial Groups ENGOT | OTHER |
| GOG Foundation | NETWORK |